Cargando…
The secretome of endothelial progenitor cells: a potential therapeutic strategy for ischemic stroke
Ischemic stroke continues to be a leading cause of mortality and morbidity in the world. Despite recent advances in the field of stroke medicine, thrombolysis with recombinant tissue plasminogen activator remains as the only pharmacological therapy for stroke patients. However, due to short therapeu...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323700/ https://www.ncbi.nlm.nih.gov/pubmed/33433461 http://dx.doi.org/10.4103/1673-5374.303012 |